Synthesis of novel pyrazolo[3,4-b]pyridine derivatives in aqueous medium

Article abstract of DOI:10.24820/ark.5550190.p010.389

A synthesis of 5-(3,3-dimethyl-3H-indol-2-yl)-3-methyl-1H-pyrazolo[3,4-b]pyridines by the reaction of variously substituted aminomethylene malondialdehydes [2-(3,3-dimethyl-3H-indol-2-ylidene)malondialdehydes] with 5-amino-1-aryl-3-methylpyrazoles in the presence of p-toluenesulfonic acid in water is described.

Full text of DOI:10.24820/ark.5550190.p010.389

The Free Internet Journal
for Organic Chemistry
Paper
Archive for
Organic Chemistry
Arkivoc 2018, part iv, 114-122
Synthesis of novel pyrazolo[3,4-b]pyridine derivatives in aqueous medium
Mehdi M. Baradarani,*a Hadi Zare Fazlelahi,a Ahmad Rashidi,a,b and John A. Joulec
aFaculty of Chemistry, University of Urmia, Urmia 57153-165, Iran
bSaba College of Higher Education, Urmia 57166-53847, Iran
cThe School of Chemistry, The University of Manchester, M13 9PL, UK
Email: mehdi.baradarani@gmail.com
This paper is dedicated to Gordon Gribble on his retirement – indole chemist par excellence
and delightful collaborator. A true gentleman and fine chemist.
Received 11-08-2017
Accepted 02-12-2018
Published on line 03-14-2018
Abstract
A synthesis of 5-(3,3-dimethyl-3H-indol-2-yl)-3-methyl-1H-pyrazolo[3,4-b]pyridines by the reaction of variously
substituted aminomethylene malondialdehydes [2-(3,3-dimethyl-3H-indol-2-ylidene)malondialdehydes] with 5-
amino-1-aryl-3-methylpyrazoles in the presence of p-toluenesulfonic acid in water is described.
Keywords: Indolenine, aminomethylene malondialdehydes, aminopyrazole, pyrazolopyridine, water
DOI: https://doi.org/10.24820/ark.5550190.p010.389
Page 114
©ARKAT USA, Inc

Arkivoc 2018, iv, 114-122
Baradarani, M. M. et al.
Introduction
The indole moiety is a well-known heterocycle, an important feature of many natural products and medicinal
agents,1 and has been of continuing interest throughout the research work of the Dedicatee. Many methods are
available for the construction and modification of indoles.2 Indole derivatives, such as indolenines (3H-indoles),
have received considerable attention due to their wide application in synthesis, especially for photoswitchable
compounds, such as spiropyrans,3 spirooxazines3,4 and cyanine dyes.5,6 In recent years, our research group has
been developing a project centered on the synthesis of novel indolenines and bisindolenines, and reactions of
them with the Vilsmeier reagent to produce aminomethylene malondialdehydes.7-14 These malondialdehydes,
as 1,3-dicarbonyl compounds, can be used to produce new heterocyclic systems, illustrated in Scheme 1 using
the simplest example, malondialdehyde 1, leading to: pyrazoles 2,8-13 isoxazole 3,12 pyrimidines 4 and 5,12,13
pyridopyrimidinedione 614 and in work by others, oxygen-bridged diazocine 7.15
Scheme 1. Previous examples of the use of 2-(3,3-dimethyl-3H-indol-2-ylidene)malondialdehydes for
heterocycle construction.6-15
Fused heterocycles containing pyrazolopyridine systems have been associated with several biological and
medicinal activities.16,17 Substituted pyrazolo[3,4-b]pyridines represent a very important building block in
Page 115
©ARKAT USA, Inc

Arkivoc 2018, iv, 114-122
Baradarani, M. M. et al.
organic synthesis and numerous studies have been reported due to their well-documented biological
activity.18,19
The use of water as a solvent in organic chemistry was ‘rediscovered’ in the 1980s by Breslow20 who showed
that hydrophobic effects can strongly enhance the rate of organic reactions. The unique properties of aqueous
reaction media are associated with the high dielectric constant and cohesive energy density of water, that can
result in extraordinary effects on reaction rates.21 Moreover, the cost-effectiveness, abundance, non-
inflammability and non-toxic nature of water encourage its use.22-24
Herein, we report the synthesis of new pyrazolo[3,4-b]pyridines 12a-m by the reaction of malondialdehydes
10a-c and electron-rich aminopyrazoles 11a-e in the presence of p-toluenesulfonic acid in water as a green
solvent.
Results and Discussion
2,3,3-Trimethyl-3H-indoles (indolenines) 9a-c were synthesized by the reaction of the relevant phenylhydrazine
hydrochloride 8a-c with isopropyl methyl ketone in a Fischer reaction25 (Scheme 2). Each of the indolenines 9a-
c was then reacted with the Vilsmeier reagent to afford indole-malonaldehydes 10a-c in excellent yields,
according to our prior protocol.7-14 The malondialdehyde 10c is a new example and its structure rests on the
1
observation of two H NMR one-hydrogen singlets at δH 9.75 and 9.78 corresponding to the aldehyde protons
and a one-hydrogen signal for the N-hydrogen appearing at δH 13.60.
Scheme 2. Synthesis of 2-(3,3-dimethyl-3H-indol-2-ylidene)malondialdehydes.
After some preliminary experiments, it was found that a mixture of aminomethylene malondialdehyde 10a
and 3-methyl-1-phenyl-1H-pyrazol-5-amine 11a26 in the presence of p-TSA, in refluxing water for 12 hours,
afforded 5-(3,3-dimethyl-3H-indol-2-yl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]pyridine 12a in 85% yield
(Scheme 3). It should be mentioned that when the reaction of aminomethylene 10a with aminopyrazole 11a
was attempted in the absence of acid for 12 hours under reflux in water, the yield of product 12a was less than
10%. We also examined these cyclizing condensations in ethanol as solvent or cosolvent: 12a was formed in 80%
yield in refluxing ethanol after two days and in 50% yield in refluxing ethanol/water (1:1) after four days.
Page 116
©ARKAT USA, Inc

Arkivoc 2018, iv, 114-122
Baradarani, M. M. et al.
Yields
12a-g
(%)
R1
R2
Ar
Yields
12h-m
(%)
R1
R2
Ar
a (85)
b (70)
c (80)
d (81)
e (73)
f (67)
g (69)
H
H
H
H
H
Cl
Cl
H
H
H
H
H
H
H
Ph
h (62)
i (89)
j (80)
k (73)
l (79)
m (81)
Cl
H
H
H
H
H
H
3-ClC6H4
Ph
2-ClC6H4
3-ClC6H4
4-ClC6H4
4-BrC6H4
2-ClC6H4
3-ClC6H4
4-ClC6H4
4-BrC6H4
Ph
Br
Br
Br
Br
Br
2-ClC6H4
Scheme 3. Reaction of 2-(3,3-dimethyl-3H-indol-2-ylidene)malondialdehydes 10 with 3-methyl-1-phenyl-1H-
pyrazol-5-amines 11 producing 5-(3,3-dimethyl-3H-indol-2-yl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]pyridines
12.
Encouraged by this success, we extended this process to other aminomethylene malondialdehydes 10b and
10c and 5-aminopyrazoles 11b and 11e26 under similar conditions (p-TSA/H2O at reflux), furnishing the
respective compounds 12b-m in high yields (Scheme 3).
Each of the pyrazolo[3,4-b]pyridines 12a-m showed three-hydrogen singlets for the methyl protons in the
range δH 1.65-2.76 and aromatic proton signals between δH 7.18 and 9.39. For example, for compound 12a,
there was a six-hydrogen singlet for the geminal methyl groups at δH 1.68, and a three-hydrogen singlet at 2.74
for the pyrazole methyl protons. The signals between δH 7.32 and 9.38 were evidence for the aromatic-protons,
and two one-hydrogen singlets at δH 8.94 and 9.38 characterized the newly-formed pyridine ring. The 13C NMR
spectrum of compound 12a showed 20 signals in agreement with the structure.
Conclusions
An examination of p-TSA catalyzed cyclocondensations of (3H-indol-2-ylidene)malondialdehydes and various 5-
aminopyrazoles in boiling water afforded pyrazolo[3,4-b]pyridines. The cyclocondensation reactions were clean
and the new crystalline 5-(3,3-dimethyl-3H-indol-2-yl)pyrazolo[3,4-b]pyridines 12a-m were obtained in high
yields.
Page 117
©ARKAT USA, Inc

Arkivoc 2018, iv, 114-122
Baradarani, M. M. et al.
Experimental Section
General. Melting points were recorded on an Electrothermal Engineering LTD 16218 (Bibby Scientific Limited,
Staffordshire, UK). 1H and 13C NMR spectra were recorded on an Avance AQS 300 MHz spectrometer (Brucker,
Karlsruhe, Germany) at 300 and 75 MHz, respectively. Chemical shifts δ are in parts per million (ppm) measured
in CDCl3 as solvent and relative to TMS as the internal standard. Infrared spectra were recorded on a Nexus 670
FT-IR instrument (Thermonicolet, USA). Microanalyses were performed on a Perkin Elmer series II 2400 Analyzer
(Perkin Elmer, USA).
5-Bromo-2,3,3-trimethyl-3H-indole (9c). A mixture of 4-bromophenylhydrazine hydrochloride 8c (0.010 mol,
2.23 g) and isopropyl methyl ketone (0.011 mol, 1.18 mL) was refluxed in acetic acid (25 mL) for 6 h and then
cooled, diluted with cold water (50 mL), and neutralized with NaOH (2 M), then extracted with EtOAc (2 × 50
mL). The organic layer was dried (Na2SO4) and solvent was evaporated to give 9c as a viscous oil, which was
o
crystallized from EtOH/H2O (1:1). Red crystals; (1.78 g, 75%); mp 35-36 C; FT-IR (KBr) νmax/cm–1: 3059, 2954,
2926, 1583, 1462, 1381, 1197, 1076, 1012, 817; 1H NMR (CDCl3): δH 1.29 (s, 6H), 2.26 (s, 3H), 7.39-7.41 (m, 3H);
13C NMR (CDCl3): δC 15.4, 22.9, 54.1, 118.9, 121.2, 124.9, 130.7, 147.8, 152.6, 188.5; Found: C, 55.39; H, 5.01; N,
6.02. C11H12BrN requires: C, 55.48; H, 5.08; N, 5.88%.
2-(5-Bromo-3,3-dimethyl-3H-indol-2-ylidene)malonaldehyde (10c). To N,N-dimethylformamide (0.3 mol, 23
o
mL) cooled in an ice bath was added dropwise POCl3 (0.15 mol, 13.7 mL) with stirring at below 5 C. After this
addition, a solution of 5-bromo-2,3,3-trimethyl-3H-indole (9c) (0.05 mol, 11.90 g) in DMF (0.15 mol, 11 mL) was
o
added dropwise. The cooling bath was removed and the reaction mixture was stirred at 75 C for 12 h. The
resulting solution was added to ice-cooled water and made alkaline with aq NaOH solution. The resulting
precipitate was collected by filtration after 12 h, dried and recrystallized from EtOH, to give the title compound
o
10c. Light brown crystals;(13.52 g, 92%); mp 114-117 C; FT-IR (KBr) νmax/cm–1: 3215, 3086, 2969, 2929, 2867,
1
2768, 1656, 1607, 1525, 1465, 1365, 1196, 1159, 815; H NMR (CDCl3): δH 1.75 (s, 6H), 7.07 (d, J 8.4 Hz, 1H),
7.43-7.45( m, 2H), 9.75 (s, 1H), 9.78 (s, 1H), 13.60 (bs, 1H, NH); 13C NMR (CDCl3): δC 23.3, 51.5, 109.5, 113.9,
118.8, 125.8, 131.3, 138.4, 142.8, 162.3, 179.0, 187.6; Found: C, 53.16; H, 4.04; N, 4.69. C13H12BrNO2 requires:
C, 53.08; H, 4.11; N, 4.76%.
General procedure for synthesis of pyrazolo[3,4-b]pyridines 12a-m. p-TSA (0.086 g, 0.5 mmol) was added to a
mixture of an aminomethylene malondialdehyde 10a-c (1 mmol) and 5-aminopyrazole 11a-e (1 mmol) in H2O
(25 mL), and the mixture was heated with stirring at reflux for 12-15 h. After this time, there was no trace of
either of the starting materials in the crude product; the crude product showed just one spot on TLC. The mixture
was cooled, and the resulting precipitate was collected by filtration, dried and recrystallized from EtOH to afford
the product (12a-m).
5-(3,3-Dimethyl-3H-indol-2-yl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]pyridine (12a). Yellow crystals; (0.30 g,
o
1
85%); mp 80-82 C; FT-IR (KBr) νmax/cm–1: 3059, 2965, 2873, 1598, 1502, 1443, 1268, 1110, 759, 689; H NMR
(CDCl3): δH 1.68 (s, 6H), 2.74 (s, 3H), 7.33 (d, J 6.0 Hz, 2H), 7.40 (d, J 7.2 Hz, 2H), 7.55 (t, J 7.8 Hz, 2H), 7.73 (d, J
8.1 Hz, 1H), 8.28 (d, J 8.1 Hz, 2H), 8.94 (s, 1H), 9.38 (s, 1H); 13C NMR (CDCl3): δC 13.6, 24.2, 54.0, 117.4, 119.9,
122.0, 123.0, 125.0, 126.9, 128.2, 128.7, 129.1, 130.1, 131.0, 147.6, 148.1, 149.8, 150.3, 152.8, 181.5; Found: C,
78.28; H, 5.68; N, 15.81. C23H20N4 requires: C, 78.38; H, 5.72; N, 15.90%.
1-(2-Chlorophenyl)-5-(3,3-dimethyl-3H-indol-2-yl)-3-methyl-1H-pyrazolo[3,4-b]pyridine
(12b).
Yellow
o
crystals; (0.27 g, 70%); mp 99-100 C; FT-IR (KBr) νmax/cm–1: 3058, 2962, 2933, 1716, 1596, 1504, 1456, 1252,
1094, 1038, 759, 603; 1H NMR (CDCl3): δH 1.66 (s, 6H), 2.75 (s, 3H), 7.32 (d, J 6.6 Hz, 1H), 7.39 (d, J 7.8 Hz, 2H),
13
7.43-7.48 (m, 2H), 7.55-7.64 (m, 2H), 7.73 (d, J 6.9 Hz, 1H), 8.98 (s, 1H), 9.33 (s, 1H); C NMR (CDCl3): δC 12.7,
Page 118
©ARKAT USA, Inc

Arkivoc 2018, iv, 114-122
Baradarani, M. M. et al.
24.8, 53.6, 116.0, 120.8, 121.0, 123.1, 126.1, 127.6, 128.0, 129.8, 130.3, 130.7, 132.2, 135.6, 144.6, 147.2, 149.4,
151.9, 152.8, 162.3, 181.2; Found: C, 71.24; H, 4.88; N, 14.62. C23H19ClN4 requires: C, 71.40; H, 4.95; N, 14.48%.
1-(3-Chlorophenyl)-5-(3,3-dimethyl-3H-indol-2-yl)-3-methyl-1H-pyrazolo[3,4-b]pyridine
(12c).
Orange
crystals; (0.32 g, 82%); mp 71-73 C; FT-IR (KBr) νmax/cm–1: 3065, 2962, 2928, 1590, 1479, 1324, 1227, 1161,
1100, 1013, 876, 764, 678, 566; 1H NMR (CDCl3): δH 1.67 (s, 6H), 2.71 (s, 3H), 7.32 (d, J 4.8 Hz, 1H), 7.38-7.47 (m,
4H), 7.73 (d, J 6.3 Hz, 1H), 8.30 (d, J 7.5 Hz, 1H), 8.42 (s, 1H), 8.92 (s, 1H), 9.36 (s, 1H); 13C NMR (CDCl3): δC 12.6,
24.8, 53.6, 117.6, 118.3, 120.5, 120.9, 121.0, 123.4, 125.6, 126.2, 128.0, 130.1, 134.8, 140.3, 144.6, 147.3, 149.0,
151.0, 152.9, 162.3, 181.0; Found: C, 71.45; H, 4.89; N, 14.61. C23H19ClN4 requires: C, 71.40; H, 4.95; N, 14.48%.
o
1-(4-Chlorophenyl)-5-(3,3-dimethyl-3H-indol-2-yl)-3-methyl-1H-pyrazolo[3,4-b]pyridine
(12d).
Orange
crystals; (0.31 g, 81%); mp 150-151 oC; FT-IR (KBr) νmax/cm–1: 3069, 2967, 2928, 1709, 1594, 1495, 1449, 1399,
1266, 1087, 940, 818, 759; 1H NMR (CDCl3): δH 1.67 (s, 6H), 2.72 (s, 3H), 7.33 (d, J 6.3 Hz, 1H), 7.39 (d, J 6.6 Hz,
2H), 7.49 (d, J 7.2 Hz, 2H), 7.73 (d, J 6.9 Hz, 1H), 8.30 (d, J 7.2 Hz, 2H), 8.92 (s, 1H), 9.36 (s, 1H); 13C NMR (CDCl3):
δC 12.6, 23.7, 53.6, 117.5, 119.8, 120.7, 122.1, 122.9, 123.3, 125.2, 127.0, 128.0, 129.1, 130.2, 131.1, 144.5,
147.7, 148.1, 150.3, 181.1; Found: C, 71.33; H, 4.88; N, 14.53. C23H19ClN4 requires: C, 71.40; H, 4.95; N, 14.48%.
1-(4-Bromophenyl)-5-(3,3-dimethyl-3H-indol-2-yl)-3-methyl-1H-pyrazolo[3,4-b]pyridine
(12e).
Yellow
crystals; (0.314 g, 73%); mp 139-140 oC; FT-IR (KBr) νmax/cm–1: 3067, 2963, 2871, 1590, 1492, 1453, 1390, 1266,
1
1076, 1015, 817, 761, 570; H NMR (CDCl3): δH 1.67 (s, 6H), 2.71 (s, 3H), 7.33-7.39 (m, 3H), 7.57-7.71 (m, 3H),
8.23 (d, J 7.2 Hz, 2H), 8.92 (s, 1H), 9.36 (s, 1H); 13C NMR (CDCl3): δC 12.6, 24.8, 53.6, 117.5, 118.9, 120.8, 121.0,
122.0, 123.3, 126.2, 128.0, 129.8, 131.4, 132.1, 138.3, 144.5, 147.2, 149.0, 152.8, 181.1; Found: C, 63.92; H,
4.35; N, 12.86. C23H19BrN4 requires: C, 64.05; H, 4.44; N, 12.99%.
5-(7-Chloro-3,3-dimethyl-3H-indol-2-yl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]pyridine (12f). Yellow crystals;
(0.26 g, 67%); mp 96-98 oC; FT-IR (KBr) νmax/cm–1: 3060, 2963, 2928, 1598, 1502, 1438, 1295, 1215, 1106, 757,
1
683; H NMR (CDCl3): δH 1.68 (s, 6H), 2.75 (s, 3H), 7.29-7.38 (m, 3H), 7.53-7.58 (m, 3H), 8.29 (d, J 7.8 Hz, 2H),
9.01 (s, 1H), 9.38 (s, 1H); 13C NMR (CDCl3): δC 12.7, 24.8, 54.9, 117.3, 119.4, 121.0, 122.7, 125.1, 125.9, 127.1,
128.0, 128.5, 129.2, 130.4, 139.1, 144.2, 149.0, 149.7, 150.9, 182.2; Found: C, 71.45; H, 4.91; N, 14.61. C23H19ClN4
requires: C, 71.40; H, 4.95; N, 14.48%.
5-(7-Chloro-3,3-dimethyl-3H-indol-2-yl)-1-(2-chlorophenyl)-3-methyl-1H-pyrazolo[3,4-b]pyridine
(12g).
Orange crystals; (0.29 g, 69%); mp 106-107 oC; FT-IR (KBr) νmax/cm–1: 3063, 2959, 2927, 2868, 1601, 1513, 1454,
1292, 1162, 1102, 757; 1H NMR (CDCl3): δH 1.66 (s, 6H), 2.76 (s, 3H), 7.18-7.26 (m, 2H), 7.37-7.49 (m, 3H), 7.58-
7.65 (m, 2H), 9.04 (s, 1H), 9.33 (s, 1H); 13C NMR (CDCl3): δC 12.8, 24.8, 54.9, 116.0, 119.4, 120.4, 122.8, 125.9,
126.6, 127.1, 127.6, 128.2, 128.5, 129.7, 130.3, 130.7, 132.2, 135.6, 144.7, 149.2, 162.3, 182.2; Found: C, 65.48;
H, 4.25; N, 13.44. C23H18Cl2N4 requires: C, 65.57; H, 4.31; N, 13.30%.
5-(7-Chloro-3,3-dimethyl-3H-indol-2-yl)-1-(3-chlorophenyl)-3-methyl-1H-pyrazolo[3,4-b]pyridine
(12h).
o
Orange crystals; (0.26 g, 62%); mp 97-99 C; FT-IR (KBr) νmax/cm–1: 3077, 2963, 2930, 1591, 1481, 1270, 1095,
774, 679, 579; 1H NMR (CDCl3): δH 1.69 (s, 6H), 2.74 (s, 3H), 7.22-7.25 (m, 2H), 7.39-7.49 (m, 3H), 8.31 (d, J 7.2
13
Hz, 1H), 8.45 (s, 1H), 9.00 (s, 1H), 9.39 (s, 1H); C NMR (CDCl3): δC 12.7, 24.7, 54.9, 117.6, 118.4, 119.4, 120.6,
123.0, 124.8, 125.1, 125.7, 127.2, 128.5, 130.0, 130.1, 134.8, 140.3, 144.8, 149.2, 149.7, 151.1, 182.0; Found: C,
65.63; H, 4.27; N, 13.19. C23H18Cl2N4 requires: C, 65.57; H, 4.31; N, 13.30%.
5-(5-Bromo-3,3-dimethyl-3H-indol-2-yl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]pyridine (12i). Light brown
crystals; (0.38 g, 89%); mp 151-152 oC; FT-IR (KBr) νmax/cm–1: 3068, 2967, 2937, 1598, 1505, 1439, 1255, 1172,
1102, 823, 762; 1H NMR (CDCl3): δH 1.67 (s, 6H), 2.73 (s, 3H), 7.33 (t, J 7.2 Hz, 1H), 7.51-7.60 (m, 5H), 8.26 (d, J
7.8 Hz, 2H), 8.90 (s, 1H), 9.35 (s, 1H); 13C NMR (CDCl3): δC 12.6, 24.7, 54.0, 117.3, 119.8, 121.1, 122.1, 122.6,
124.6, 126.1, 129.2, 129.9, 131.1, 139.1, 144.1, 149.0, 149.3, 150.8, 151.8, 181.5; Found: C, 63.93; H, 4.37; N,
13.12. C23H19BrN4 requires: C, 64.05; H, 4.44; N, 12.99%.
Page 119
©ARKAT USA, Inc

Arkivoc 2018, iv, 114-122
Baradarani, M. M. et al.
5-(5-Bromo-3,3-dimethyl-3H-indol-2-yl)-1-(2-chlorophenyl)-3-methyl-1H-pyrazolo[3,4-b]pyridine (12j). Light
brown crystals; (0.37 g, 80%); mp 190-191 oC; FT-IR (KBr) νmax/cm–1: 3066, 2927, 2937, 1710, 1601, 1505, 1448,
1321, 1244, 1091, 1035, 880, 762, 607; 1H NMR (CDCl3): δH 1.65 (s, 6H), 2.75 (s, 3H), 7.46-7.55 (m, 4H), 7.57-7.67
(m, 3H), 8.95 (s, 1H), 9.31 (s, 1H); 13C NMR (CDCl3): δC 12.7, 24.7, 54.0, 116.0, 119.8, 122.1, 122.7, 124.6, 127.7,
129.7, 130.1, 130.3, 130.7, 131.1, 132.2, 135.5, 144.6, 149.3, 149.4, 151.8, 152.0, 181.5; Found: C, 59.18; H,
3.83; N, 11.91. C23H18BrClN4 requires: C, 59.31; H, 3.90; N, 12.03%.
5-(5-Bromo-3,3-dimethyl-3H-indol-2-yl)-1-(3-chlorophenyl)-3-methyl-1H-pyrazolo[3,4-b]pyridine (12k). Light
brown crystals; (0.34 g, 73%); mp 110-111 oC; FT-IR (KBr) νmax/cm–1: 3066, 2964, 2929, 1589, 1477, 1323, 1252,
1163, 1091, 828, 776, 738, 676; 1H NMR (CDCl3): δH 1.68 (s, 6H), 2.73 (s, 3H), 7.34 (d, J 6.3 Hz, 1H), 7.37-7.49 (m,
3H), 7.73 (d, J 7.8 Hz, 1H), 8.31 (d, J 8.1 Hz, 1H), 8.43 (s, 1H), 8.94 (s, 1H), 9.38 (s, 1H); 13C NMR (CDCl3): δC 12.6,
24.8, 54.0, 117.6, 118.4, 119.9, 120.6, 122.2, 123.0, 124.6, 125.8, 130.0, 130.1, 131.2, 134.8, 140.2, 144.7, 149.0,
149.3, 151.0, 151.8, 181.3; Found: C, 59.36; H, 3.81; N, 12.16. C23H18BrClN4 requires: C, 59.31; H, 3.90; N, 12.03%.
5-(5-Bromo-3,3-dimethyl-3H-indol-2-yl)-1-(4-chlorophenyl)-3-methyl-1H-pyrazolo[3,4-b]pyridine (12l). Light
brown crystals; (0.36 g, 79%); mp 201-203 oC; FT-IR (KBr) νmax/cm–1: 3072, 2960, 2922, 2868, 1600, 1499, 1446,
1
1407, 1322, 1251, 1092, 821; H NMR (CDCl3): δH 1.67 (s, 6H), 2.72 (s, 3H), 7.48-7.56 (m, 5H), 8.30 (d, J 8.4 Hz,
2H), 8.89 (s, 1H), 9.34 (s, 1H); 13C NMR (CDCl3): δC 12.6, 24.7, 54.0, 117.4, 119.9, 121.8, 122.2, 122.8, 124.6,
129.2, 129.9, 131.2, 137.8, 144.4, 148.9, 149.3, 150.8, 151.9, 162.3, 181.3; Found: C, 59.24; H, 3.96; N, 12.08.
C23H18BrClN4 requires: C, 59.31; H, 3.90; N, 12.03%.
5-(5-Bromo-3,3-dimethyl-3H-indol-2-yl)-1-(4-bromophenyl)-3-methyl-1H-pyrazolo[3,4-b]pyridine
(12m).
Light brown crystals; (0.41 g, 81%); mp 127-129 oC; FT-IR (KBr) νmax/cm–1: 3083, 2964, 2929, 1594, 1495, 1452,
1
1323, 1265, 1074, 1014, 825; H NMR (CDCl3): δH 1.67 (s, 6H), 2.72 (s, 3H), 7.51-7.60 (m, 3H), 7.65 (d, J 8.4 Hz,
2H), 8.25 (d, J 8.4 Hz, 2H), 8.89 (s, 1H), 9.35 (s, 1H); 13C NMR (CDCl3): δC 12.6, 24.7, 54.0, 117.5, 119.0, 119.9,
122.1, 122.2, 122.9, 124.6, 131.2, 132.2, 138.3, 144.5, 149.3, 150.9, 151.8, 162.3, 167.2, 181.3; Found: C, 54.03;
H, 3.50; N, 11.16. C23H18Br2N4 requires: C, 54.14; H, 3.56; N, 10.98%.
Acknowledgements
The authors are grateful to the University of Urmia for financial support of this work.
Supplemental Data
Supplementary data (1H NMR and 13C NMR spectra of all the products) associated with this article can be found
in the online version.
References
1. Indole ring synthesis: from natural products to drug discovery; Gribble, G. W., Wiley, 2016.
2. Joule, J. A., 'Indoles', in Science of Synthesis, Vol 10 Knowledge Update 2010/2, Ed. Thomas, E. J., Georg
Thieme Verlag: Stuttgart, New York, 2011; 526 pp.
3. Berkovic, G.; Krongauz, V.; Weiss, V. Chem. Rev. 2000, 100, 1741.
https://doi.org/10.1021/cr9800715
Page 120
©ARKAT USA, Inc

Arkivoc 2018, iv, 114-122
Baradarani, M. M. et al.
4. Petersen, M. A.; Deniz, E.; Nielsen, M. B.; Sortino, S.; Raymo, F. M. Eur. J. Org. Chem. 2009, 4333.
https://doi.org/10.1002/ejoc.200900604
5. Mahmood, T.; Paul, A.; Ladame, S. J. Org. Chem. 2010, 75, 204.
https://doi.org/10.1021/jo901820t
6. Meguellati, K.; Spichty, M.; Ladame, S. Org. Lett. 2009, 11, 1123.
https://doi.org/10.1021/ol802913b
7. Helliwell, M.; Afgan, A.; Baradarani, M. M.; Joule, J. A. Acta Cryst. Sect. E 2006, 62, o737.
https://doi.org/10.1107/S1600536806002261
8. Baradarani, M. M.; Afghan, A.; Zebarjadi, F.; Hasanzadeh, K.; Joule, J. A. J. Heterocycl. Chem. 2006, 43, 1591.
https://doi.org/10.1002/jhet.5570430624
9. Rashidi, A.; Afghan, A.; Baradarani, M. M.; Joule, J. A. J. Heterocycl. Chem. 2009, 46, 428.
https://doi.org/10.1002/jhet.18
10. Helliwell, M.; Afghan, A.; Keshvari, F.; Baradarani, M. M.; Joule, J. A. Acta Cryst. Sect. E 2010, 66, o112.
https://doi.org/10.1107/S1600536809052581
11. Rashidi, A.; Baradarani, M. M.; Joule, J. A. Arkivoc 2011, (ii), 252.
http://dx.doi.org/10.3998/ark.550190.0012.220
12. Afghan, A.; Roohi, L.; Baradarani, M. M.; Joule, J. A. J. Heterocycl. Chem. 2014, 51, 706.
https://doi.org/10.1002/jhet.1735
13. Alyari, M.; Baradarani, M. M.; Afghan, A.; Joule, J. A. J. Heterocycl. Chem. 2014, 51, 854.
https://doi.org/10.1002/jhet.1626
14. Rashidi, A.; Baradarani, M. M.; Joule, J. A. J. Heterocycl. Chem. 2014, 51, 1068.
https://doi.org/10.1002/jhet.2102
15. Faraj, F. L.; Khaledi, H.; Karimian, H.; Ali, H. M. J. Heterocycl. Chem. 2017, 54, 2071.
https://doi.org/10.1002/jhet.2772
16. El-Borai, M. A.; Rizk, H. F.; Beltagy, D. M.; El-Deeb, I. Y. Eur. J. Med. Chem. 2013, 66, 415-422.
https://doi.org/10.1016/j.ejmech.2013.04.043
17. Qin, J.; Zhou, W.; Huang, X.; Dhondi, P.; Palani, A.; Aslanian, R.; Zhu, Z.; Greenlee, W.; Cohen-Williams, M.;
Jones, N.; Hyde, L.; Zhang, L. ACS Med. Chem. Lett. 2011, 2, 471.
https://doi.org/10.1021/ml2000438
18. Mello, H.; Echevarria, A.; Bernardino, A. M.; Canto-Cavalheiro, M.; Leon, L. L. J. Med. Chem. 2004, 47, 5427.
https://doi.org/10.1021/jm0401006
19. Ochiai, H.; Ishida, A.; Ohtani, T.; Kusumi, K.; Kishikawa, K.; Yamamoto, S.; Takeda, H.; Obata, T.; Nakaia, H.;
Toda, M. Bioorg. Med. Chem. 2004, 12, 4089.
https://doi.org/10.1016/j.bmc.2004.05.032
20. Breslow, R.; Rideout, D. C. J. Am. Chem. Soc. 1980, 102, 7816.
https://doi.org/10.1021/ja00546a048
21. Rahmati, A.; Rezayan, A. H.; Alizadeh, M.; Nikbakht, A. J. Iran. Chem. Soc. 2013, 10, 521.
https://doi.org/10.1007/s13738-012-0187-z
22. Zhao, L. Q.; Zhou, B.; Li, Y. Q. Heteroatom Chem. 2011, 22, 673.
https://doi.org/10.1002/hc.20723
23. Kidwai, M.; Saxena, S.; Khan, M. K. R. ; Thukral, S. S. Bioorg. Med. Chem. Lett. 2005, 15, 4295.
https://doi.org/10.1016/j.bmcl.2005.06.041
24. Li, C. J. Chem. Rev. 2005, 105, 3095.
https://doi.org/10.1021/cr030009u
Page 121
©ARKAT USA, Inc

Arkivoc 2018, iv, 114-122
Baradarani, M. M. et al.
25. Robinson, B. The Fischer Indole Synthesis; Wiley: New York, 1982.
26. Ganesan, A.; Heathcock, C. H. J. Org. Chem. 1993, 58, 6155.
https://doi.org/10.1021/jo00074a058
Page 122
©ARKAT USA, Inc